BrainStorm Announces Financial Results for the Second Quarter of 2020 and Provides a Corporate Update

Go back to BrainStorm Announces Financial Results for the Second Quarter of 2020 and Provides a Corporate Update

Brainstorm Cell Therapeutics (BCLI) Tops Q2 EPS by 1c

August 5, 2020 7:22 AM EDT

Brainstorm Cell Therapeutics (NASDAQ: BCLI) reported Q2 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Brainstorm Cell Therapeutics (BCLI) click here.

... More